skip to main content
Global Search Configuration

Select Catalysts from Last Quarter's Outlook Report

What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free. 

This vital infographic contains critical data about Golodirsen for Duchenne Muscular Dystrophy (DMD), Recarbrio for Intra-Abdominal Infections, and Recarbrio for Urinary Tract and Reproductive Tract Infections, including: 
The catalyst that occurred
Trial results
Biomedtracker’s Likelihood of Approval (LOA) analysis
5-day stock performance surrounding the catalyst event
Other notable upcoming catalysts for the drugs
Reactions from SAGE and Aevi Genomic 


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: